Phase I Study of Intrathecal Topotecan

NCT00001333 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Leukemia
Lymphoma
Meningeal Neoplasms

Interventions

DRUG: topotecan

Sponsor

National Cancer Institute (NCI)